Mode
Text Size
Log in / Sign up
Phase 2 N=24 Randomized Double-blind Treatment

Use of Mineral Trioxide Aggregate in the Treatment of Traumatized Teeth

Periapical Diseases

Enrolled (actual)
24
Serious AEs
Results posted
Jul 2017
Primary outcome: Primary: Changes Between Initial and Post Treatment Dimensions of Periapical Lesions — 37.34; 34.04; 16.20; 17.54 square millimeters — p=<0.01

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
ProRoot MTA (Device); MTA+ Cerkamed (Device)
Age
Pediatric, Adult · 7+ yrs
Sex
All
Sponsor
Association of Paediatric and Preventive Dentists of Serbia
Primary completion
Dec 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Changes Between Initial and Post Treatment Dimensions of Periapical Lesions
37.34; 34.04; 16.20; 17.54; 12.74; 12.01 <0.01 sig
SECONDARY
Presence of Clinical Symptoms
5; 5; 8; 6; 3; 1

Summary

Traumatic tooth injuries are common in children and adolescents, and often result in pulpal necrosis and the development of periapical lesions. Treatment of traumatized teeth with endodontic complications depends on the type of injury, number of injured teeth, root development and patient cooperation, which altogether will create a challenge and dictate the treatment plan for the dentist. The purpose of this study was to assess the effectiveness of non-surgical root canal procedures in traumatized permanent teeth with necrotic pulps and chronic periapical lesions using a tri-antibiotic paste and calcium-hydroxide as intracanal medications and two different mineral trioxide aggregate (MTA) products for definitive obturation.

Eligibility Criteria

Inclusion Criteria

  • Healthy patient
  • Non-vital tooth with chronic periapical lesions
  • Restorable tooth
  • No horizontal or vertical root fractures
  • No root resorption

Exclusion Criteria

  • Unrestorable tooth
  • Horizontal or vertical root fractures
  • Root resorption
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02625298). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search